Literature DB >> 3813671

Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 autopsy cases.

S Lakhanpal, J T Lie, D L Conn, W J Martin.   

Abstract

The clinical and autopsy records of 65 patients with either polymyositis (24) or dermatomyositis (41) and pulmonary disease were reviewed. Pulmonary symptoms were recorded in 43 of the cases and included dyspnoea in 31, cough in 23, and chest pain in six. Interstitial lung disease was noted at autopsy in 27 patients; almost half of these had arthritis. Bronchopneumonia was found in 35 patients, 31 of these had received prednisone. Dysphagia was present in a similar proportion of patients with and without pneumonia. Pulmonary vasculitis was seen in five patients; pulmonary symptoms, arthritis, and raised erythrocyte sedimentation rate were present in four of these cases and all five had associated interstitial lung disease. Other pulmonary manifestations included pulmonary oedema, primary pulmonary malignancy, diffuse alveolar damage, fibrinous pleuritis, pulmonary emboli, and diaphragmatic atrophy. The mean survival after disease onset was 29 months but was much less for those with interstitial lung disease and pulmonary vasculitis.

Entities:  

Mesh:

Year:  1987        PMID: 3813671      PMCID: PMC1002053          DOI: 10.1136/ard.46.1.23

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  22 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

Review 2.  Pulmonary involvement in the collagen vascular diseases.

Authors:  G W Hunninghake; A S Fauci
Journal:  Am Rev Respir Dis       Date:  1979-03

3.  Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis.

Authors:  A Bohan; J B Peter; R L Bowman; C M Pearson
Journal:  Medicine (Baltimore)       Date:  1977-07       Impact factor: 1.889

4.  Fibrosing alveolitis in polymyositis. A review of histologically confirmed cases.

Authors:  P E Duncan; J P Griffin; A Garcia; S B Kaplan
Journal:  Am J Med       Date:  1974-10       Impact factor: 4.965

Review 5.  Pulmonary disease in polymyositis/dermatomyositis.

Authors:  B F Dickey; A R Myers
Journal:  Semin Arthritis Rheum       Date:  1984-08       Impact factor: 5.532

Review 6.  Interstitial lung disease: current concepts of pathogenesis, staging and therapy.

Authors:  R G Crystal; J E Gadek; V J Ferrans; J D Fulmer; B R Line; G W Hunninghake
Journal:  Am J Med       Date:  1981-03       Impact factor: 4.965

7.  Interstitial lung disease in polymyositis and dermatomyositis: analysis of six cases and review of the literature.

Authors:  M I Schwarz; R A Matthay; S A Sahn; R E Stanford; B L Marmorstein; D J Scheinhorn
Journal:  Medicine (Baltimore)       Date:  1976-01       Impact factor: 1.889

8.  Pulmonary hypertension in polymyositis.

Authors:  T W Bunch; R G Tancredi; J T Lie
Journal:  Chest       Date:  1981-01       Impact factor: 9.410

9.  Interstitial lung disease in polymyositis and dermatomyositis.

Authors:  S Songcharoen; S F Raju; J B Pennebaker
Journal:  J Rheumatol       Date:  1980 May-Jun       Impact factor: 4.666

10.  Intraluminal fibrosis in interstitial lung disorders.

Authors:  F Basset; V J Ferrans; P Soler; T Takemura; Y Fukuda; R G Crystal
Journal:  Am J Pathol       Date:  1986-03       Impact factor: 4.307

View more
  14 in total

Review 1.  Organising pneumonia.

Authors:  J F Cordier
Journal:  Thorax       Date:  2000-04       Impact factor: 9.139

Review 2.  Polymyositis/dermatomyositis: the current position.

Authors:  A Urbano-Márquez; J Casademont; J M Grau
Journal:  Ann Rheum Dis       Date:  1991-03       Impact factor: 19.103

3.  Inflammatory myopathy, bronchiolitis obliterans/organizing pneumonia, and anti-Jo-1 antibodies--an interesting association.

Authors:  M Kalenian; B Zweiman
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

Review 4.  Polymyositis-dermatomyositis: a clinical review.

Authors:  K W Strauss; H Gonzalez-Buritica; M A Khamashta; G R Hughes
Journal:  Postgrad Med J       Date:  1989-07       Impact factor: 2.401

Review 5.  Interstitial lung disease in polymyositis and dermatomyositis.

Authors:  Armin Schnabel; Bernhard Hellmich; Wolfgang Ludwig Gross
Journal:  Curr Rheumatol Rep       Date:  2005-04       Impact factor: 4.592

Review 6.  Interstitial lung disease in inflammatory myopathies: clinical phenotypes and prognosis.

Authors:  Patrick D W Kiely; Felix Chua
Journal:  Curr Rheumatol Rep       Date:  2013-09       Impact factor: 4.592

7.  Clinical characteristics and outcomes of patients with idiopathic inflammatory myopathies from Jordan 1996-2009.

Authors:  Khader N Mustafa; Said S Dahbour
Journal:  Clin Rheumatol       Date:  2010-04-21       Impact factor: 2.980

8.  HRCT score and serum ferritin level are factors associated to the 1-year mortality of acute interstitial lung disease in clinically amyopathic dermatomyositis patients.

Authors:  Jing Zou; Qiang Guo; Jiachang Chi; Huawei Wu; Chunde Bao
Journal:  Clin Rheumatol       Date:  2015-01-23       Impact factor: 2.980

9.  A case of dermatomyositis complicated with pleural effusion and massive ascites.

Authors:  Naoki Matsuoka; Tomoyuki Asano; Shuzo Sato; Tomomi Sasajima; Yuya Fujita; Jumpei Temmoku; Makiko Yashiro Furuya; Haruki Matsumoto; Eiji Suzuki; Hiroko Kobayashi; Hiroshi Watanabe; Kiyoshi Migita
Journal:  Fukushima J Med Sci       Date:  2019-12-11

10.  Activation of pulmonary T cells in corticosteroid-resistant and -sensitive interstitial pneumonitis in dermatomyositis/polymyositis.

Authors:  K Kurasawa; Y Nawata; K Takabayashi; K Kumano; Y Kita; Y Takiguchi; T Kuriyama; M Sueishi; Y Saito; I Iwamoto
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.